Effect of heparin on coronary arterial patency after thrombolysis with tissue plasminogen activator in acute myocardial infarction

The American Journal of Cardiology
S D BleichS L Teichman

Abstract

Infarct artery patency rates at 90 minutes after coronary thrombolysis using recombinant tissue-type plasminogen activator (rt-PA) with and without concurrent heparin anticoagulation have been shown to be comparable. The contribution of heparin to efficacy and safety after thrombolysis with rt-PA is unknown. In this pilot study, 84 patients were treated within 6 hours of onset of acute myocardial infarction (mean of 2.7 hours) with the standard dose of 100 mg of rt-PA over 3 hours. Forty-two patients were randomized to receive additionally immediate intravenous heparin anticoagulation (5,000 U of intravenous bolus followed by 1,000 U/hour titrated to a partial thromboplastin time of 1.5 to 2.0 times control) while 42 patients received rt-PA alone. Coronary angiography performed on day 3 (48 to 72 hours, mean 57) after rt-PA therapy revealed infarct artery patency rates of 71 and 43% in anticoagulated and control patients, respectively (p = 0.015). Recurrent ischemia or infarction, or both, occurred in 3 (7.1%) anticoagulated patients and 5 (11.9%) control patients (difference not significant). Mild, moderate and severe bleeding occurred in 52, 10 and 2% of the group receiving anticoagulation, respectively, and 34, 2 and 0% of p...Continue Reading

References

Nov 17, 1977·The New England Journal of Medicine·T C ChalmersA M Kunzler
Apr 15, 1990·The American Journal of Cardiology·E F MahanW A Baxley
Apr 1, 1989·Journal of the American College of Cardiology·R M Califf
Mar 1, 1987·The American Journal of the Medical Sciences·J T WillersonL M Buja
Feb 1, 1987·The American Journal of Cardiology·K KaplanM Salinger
Jan 1, 1986·The American Journal of Cardiology·A K GashR D Gentzler
Apr 1, 1986·Archives of Internal Medicine·G C TimmisJ R Stewart
Oct 16, 1980·The New England Journal of Medicine·M A DeWoodH T Lang

❮ Previous
Next ❯

Citations

Jul 1, 1996·Catheterization and Cardiovascular Diagnosis·R L QuigleyM H Salinger
Apr 1, 1993·Clinical Cardiology·N W ShammasP Fitzpatrick
May 1, 1996·Clinical Cardiology·G T AlmonyE J Topol
Nov 1, 1995·Journal of Clinical Pharmacology·M Gibaldi, A K Wittkowsky
Apr 1, 1992·Cardiovascular Drugs and Therapy·M Verstraete
Jan 1, 1995·Journal of Thrombosis and Thrombolysis·H D White, S Yusuf
Nov 15, 1994·The American Journal of Cardiology·J L Anderson, L A Karagounis
May 16, 1992·Lancet·B E Sobel, D Collen
Nov 1, 1994·General Pharmacology·G HanR Gollamudi
Apr 1, 1992·Journal of the American College of Cardiology·P R EisenbergA S Jaffe
Jul 1, 1993·Journal of the American College of Cardiology·N A PragerD R Abendschein
Jun 1, 1995·Journal of the American College of Cardiology·C J O'DonnellC H Hennekens
Mar 15, 1996·Journal of the American College of Cardiology·F W VerheugtM J Van Eenige
Jan 1, 1993·The Journal of Emergency Medicine·S H ThomasE J Allison
Jan 1, 1996·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·B K Metz, E J Topol
Aug 1, 1994·Mayo Clinic Proceedings·G S Reeder, S L Kopecky
Feb 1, 1993·Annals of Emergency Medicine·M S EisenbergW D Weaver
Sep 2, 1993·The New England Journal of Medicine·UNKNOWN GUSTO investigators
Sep 2, 1993·The New England Journal of Medicine·H V Anderson, J T Willerson
Dec 18, 2001·Plastic and Reconstructive Surgery·M H Conrad, W P Adams
Dec 1, 1993·Australian and New Zealand Journal of Medicine·P L ThompsonH White
Oct 20, 1998·Australian and New Zealand Journal of Medicine·C B Granger
Jun 27, 2000·Australian and New Zealand Journal of Medicine·P A Tideman
Dec 10, 1990·Journal of Interventional Cardiology·C L Grines, A N Demaria
Jun 18, 2002·Journal of Interventional Cardiology·Deepak P VivekananthanDavid J Moliterno
Dec 4, 1992·Annals of the New York Academy of Sciences·E Falk
Dec 4, 1992·Annals of the New York Academy of Sciences·D Collen, H R Lijnen
Dec 4, 1992·Annals of the New York Academy of Sciences·R J Shebuski

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Diseases: Risk Factors

Cardiovascular disease is a significant health concern. Risk factors include hypertension, obesity, dyslipidemia and smoking. Women who are postmenopausal are at an increased risk of heart disease. Here is the latest research for risk factors of cardiovascular disease.